Industry watchers and health advocates surmise that we haven’t seen the last of Yaz lawsuits or similar litigation involving Yasmin. The most recent Yasmin lawsuit was filed with US District Court, Southern District of Illinois (case # 3:2012cv11630) on behalf of five plaintiffs alleging serious Yasmin adverse events and Yaz side effects stemming from the use of the two controversial contraceptives.
Three of the plaintiffs allege Yasmin DVT (Deep Vein Thrombosis), together with Yasmin blood clots and heart blockages. Another plaintiff represents the estate of a woman who died after suffering a stroke. According to PRWeb Newswire, the victim had been using the Yasmin pill for a little over a month when she died.
Still another plaintiff alleges Yasmin gallbladder problems.
And concern with regard to Yasmin and Yaz continues to reverberate around the globe. In the wake of France recommending to the European Medicines Agency that Yasmin/Yaz be established as the birth control choice of last resort, the largest health insurer in Switzerland has revealed it is supporting a young Swiss woman in her legal claim against pharmaceutical giant Bayer.
According to Swiss media reports, the young woman suffered a pulmonary embolism just a few weeks after first prescribed the Yasmin pill. The embolism, it is reported, left the woman severely disabled. Medical costs related to the alleged Yasmin side effects have climbed to 600,000 Swiss francs, or $648,600 when converted into US currency value.
READ MORE YASMIN BIRTH CONTROL LEGAL NEWS
Metro - Boston (1/9/13) reports that Bayer has agreed to pay a combined sum of $750 million to settle 3,490 US claims related to Yasmin blood clots and similar injuries involving Yaz. Another 3,800 cases pending in the US also allege blood clot injuries. However, it should be noted that those claims - and Bayer’s agreement to settle - cover only blood clots and Yasmin DVT. They do not include other injuries allegedly associated with Yasmin or Yaz, including Yasmin gallbladder problems.
French authorities are also seeking a restriction on the use of Bayer contraceptive Ocella, due in part to concerns over Ocella side effects.